Corrigendum to: Leaky gut biomarkers in depression and suicidal behavior (Acta Psychiatrica Scandinavica, (2019), 139, (185-193), 10.1111/acps.12978);Leaky gut biomarkers in depression and suicidal behavior

Acta Psychiatrica Scandinavica

Volumn 139, Issue 2, 2019, Pages 185-193

  Ohlsson, L ^a   Gustafsson, A ^a   Lavant, E ^a   Suneson, K ^b   Brundin, L ^c   Westrin, A ^b   Ljunggren, L ^a   Lindqvist, D ^b  

^a MALMÖ UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

depressive disorder, major; intestinal fatty acid binding protein; intestinal permeability; suicide, attempted; zonulin

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN 2; INTERLEUKIN 6; CD14 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; HAPTOGLOBIN; LIPOPOLYSACCHARIDE RECEPTOR; PROTEIN PRECURSOR; ZONULIN;

ADULT; ALCOHOL ABUSE; ARTICLE; BACTERIAL TRANSLOCATION; BLOOD SAMPLING; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DSM-IV; ENZYME IMMUNOASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE; INTESTINE CELL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; MENTAL PATIENT; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; SYMPTOM ASSESSMENT; BLOOD; CROSS-SECTIONAL STUDY; CYTOLOGY; GENETICS; INFLAMMATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PERMEABILITY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SMALL INTESTINE; SUICIDAL IDEATION;

ADULT; BACTERIAL TRANSLOCATION; BIOMARKERS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; ENTEROCYTES; FATTY ACID-BINDING PROTEINS; FEMALE; HAPTOGLOBINS; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTESTINE, SMALL; LIPOPOLYSACCHARIDE RECEPTORS; MALE; MIDDLE AGED; PERMEABILITY; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX; SUICIDAL IDEATION; SUICIDE, ATTEMPTED;

EID: 85055937078     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.13223     Document Type: Erratum

References (61)

1. Dowlati Y, Herrmann N, Swardfager W et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446–457
2. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:201–217
3. Zunszain PA, Hepgul N, Pariante CM. Inflammation and depression. Curr Top Behav Neurosci. 2013;14:135–151
4. Brundin L, Erhardt S, Bryleva EY, Achtyes ED, Postolache TT. The role of inflammation in suicidal behaviour. Acta Psychiatr Scand 2015;132:192–203
5. Holmes SE, Hinz R, Conen S et al. Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: a positron emission tomography study. Biol Psychiatry 2018;83:61–69
6. Chang CC, Tzeng NS, Kao YC, Yeh CB, Chang HA. The relationships of current suicidal ideation with inflammatory markers and heart rate variability in unmedicated patients with major depressive disorder. Psychiatry Res 2017;258:449–456
7. Janelidze S, Mattei D, Westrin A, Traskman-Bendz L, Brundin L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 2011;25:335–339
8. Steiner J, Bielau H, Brisch R et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 2008;42:151–157
9. Isung J, Aeinehband S, Mobarrez F et al. High interleukin-6 and impulsivity: determining the role of endophenotypes in attempted suicide. Transl Psychiat 2014;4:e470
10. Sublette ME, Galfalvy HC, Fuchs D et al. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun 2011;25:1272–1278
11. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 2015;28:203–209
12. Fadgyas-Stanculete M, Buga AM, Popa-Wagner A, Dumitrascu DL. The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J Mol Psychiatry 2014;2:4
13. Karakula-Juchnowicz H, Szachta P, Opolska A et al. The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders. Nutr Neurosci 2017;20:110–118
14. Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci 2015;9:392
15. Sherwin E, Dinan TG, Cryan JF. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann N Y Acad Sci 2018;1420:5–25
16. Evrensel A, Ceylan ME. The gut-brain axis: the missing link in depression. Clin Psychopharmacol Neurosci 2015;13:239–244
17. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011;12:453–466
18. Jayashree B, Bibin YS, Prabhu D et al. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem 2014;388:203–210
19. Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 2008;29:117–124
20. Fasano A, Not T, Wang W et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000;355:1518–1519
21. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev 2011;91:151–175
22. Pelsers MM, Namiot Z, Kisielewski W et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem 2003;36:529–535
23. Piton G, Belin N, Barrot L et al. Enterocyte damage: a piece in the puzzle of post-cardiac arrest syndrome. Shock 2015;44:438–444
24. Adriaanse MP, Tack GJ, Passos VL et al. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther 2013;37:482–490
25. Hunt PW, Sinclair E, Rodriguez B et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis 2014;210:1228–1238
26. Shive CL, Jiang W, Anthony DD, Lederman MM. Soluble CD14 is a nonspecific marker of monocyte activation. AIDS 2015;29:1263–1265
27. Landmann R, Knopf HP, Link S, Sansano S, Schumann R, Zimmerli W. Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun 1996;64:1762–1769
28. Brenchley JM, Price DA, Schacker TW et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365–1371
29. Sandler NG, Koh C, Roque A et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 2011;141:1220–123030 e1–3
30. Heyman M, Abed J, Lebreton C, Cerf-Bensussan N. Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Gut 2012;61:1355–1364
31. Hoffmanova I, Sanchez D, Habova V, Andel M, Tuckova L, Tlaskalova-Hogenova H. Serological markers of enterocyte damage and apoptosis in patients with celiac disease, autoimmune diabetes mellitus and diabetes mellitus type 2. Physiol Res 2015;64:537–546
32. Lindqvist D, Janelidze S, Hagell P et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiat 2009;66:287–292
33. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–389
34. Nimeus A, Hjalmarsson Stahlfors F, Sunnqvist C, Stanley B, Traskman-Bendz L. Evaluation of a modified interview version and of a self-rating version of the Suicide Assessment Scale. Eur Psychiatry 2006;21:471–477
35. BLOM G. Statistical estimates and transformed beta-variables. New York: J. Wiley & sons; Stockholm: Almqvist & Wiksell, 1958
36. Stevens BR, Goel R, Seungbum K et al. Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression. Gut 2018;67:1557–1558
37. Abautret-Daly A, Dempsey E, Parra-Blanco A, Medina C, Harkin A. Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatr 2017;08:1–22
38. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012;10:735–742
39. Lowry CA, Smith DG, Siebler PH et al. The microbiota, immunoregulation, and mental health: implications for public health. Curr Environ Health Rep 2016;3:270–286
40. Kelly JR, Borre Y, O'Brien C et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 2016;82:109–118
41. Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition 2016;32:315–320
42. Pinto-Sanchez MI, Hall GB, Ghajar K et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology 2017;153:448–459 e8
43. Romijn AR, Rucklidge JJ, Kuijer RG, Frampton C. A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression. Aust N Z J Psychiatry 2017;51:810–821
44. Qin J, Li Y, Cai Z et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55–60
45. Larsen N, Vogensen FK, van Den Berg FW et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010;5:e9085
46. Ciccia F, Guggino G, Rizzo A et al. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann Rheum Dis 2017;76:1123–1132
47. Horta-Baas G, Romero-Figueroa MDS, Montiel-Jarquin AJ, Pizano-Zarate ML, Garcia-Mena J, Ramirez-Duran N. Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis. J Immunol Res 2017;2017:4835189
48. Vujkovic-Cvijin I, Dunham RM, Iwai S et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 2013;5:193ra91
49. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord 2012;142 Suppl:S8–S21
50. Morrison MF, Petitto JM, ten Have T et al. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry 2002;159:789–796
51. Meesters JJ, Bremander A, Bergman S, Petersson IF, Turkiewicz A, Englund M. The risk for depression in patients with ankylosing spondylitis: a population-based cohort study. Arthritis Res Ther 2014;16:418
52. Margaretten M, Julian L, Katz P, Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumtol 2011;6:617–623
53. Niculescu AB, Levey DF, Phalen PL et al. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Mol Psychiatry 2015;20:1266–1285
54. Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev 2013;26:2–18
55. Buhner S, Buning C, Genschel J et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut 2006;55:342–347
56. Park S, Lee Y, Lee JH. Association between energy drink intake, sleep, stress, and suicidality in Korean adolescents: energy drink use in isolation or in combination with junk food consumption. Nutr J 2016;15:87
57. Rogers GB, Keating DJ, Young RL, Wong ML, Licinio J, Wesselingh S. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry 2016;21:738–748
58. De PG, Collins SM, Bercik P, Verdu EF. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J Physiol 2014;592:2989–2997
59. Westrin A. Stress system alterations and mood disorders in suicidal patients. A review. Biomed Pharmacother 2000;54:142–145
60. Duerksen DR, Wilhelm-Boyles C, Veitch R, Kryszak D, Parry DM. A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig Dis Sci 2010;55:1026–1031
61. Schellekens DH, Grootjans J, Dello SA et al. Plasma intestinal fatty acid-binding protein levels correlate with morphologic epithelial intestinal damage in a human translational ischemia-reperfusion model. J Clin Gastroenterol 2014;48:253–260